Eli Lilly on Thursday posted better-than-expected quarterly results, although sales of its popular weight-loss drug, Zepbound ...

CVS Health (NYSE:CVS) on Thursday announced plans to discontinue operations in the individual health insurance business, also ...

Eli Lilly posted $12.73 billion in revenue in the first quarter, a 45% jump from the prior year, matching the percentage ...